Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter

Melanoma is one of the seven most common cancers in the United States, and its incidence is still increasing. Since 2011, developments in targeted therapies and immunotherapies have been essential for significantly improving overall survival rates. Prior to the advent of targeted and immunotherapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Thornton, Jessica, Chhabra, Gagan, Singh, Chandra K., Guzmán-Pérez, Glorimar, Shirley, Carl A., Ahmad, Nihal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066268/
https://www.ncbi.nlm.nih.gov/pubmed/35515106
http://dx.doi.org/10.3389/fonc.2022.880876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066268/
https://www.ncbi.nlm.nih.gov/pubmed/35515106
http://dx.doi.org/10.3389/fonc.2022.880876

Ejemplares similares